Digital Therapeutics Company Secures $10M in Funding

The mHealth app provides individualized exercise plans to help users alleviate chronic pain.

Thumbnail and image above courtesy of Kaia Health.

A digital therapeutics company called Kaia Health has secured $10 million in Series A funding for a chronic pain management mHealth app, according to an announcement.

Kaia Health, a Europe-based startup with offices in London and Germany, will use the money to fund clinical trials and launch a New York City office.

The app uses machine learning to create an affordable, home-based alternative to painkillers or one-on-one in-person physiotherapy.

>> READ: Health Tech Kicks Off 2019 with $119M in Funding

Kaia offers individualized exercise plans to help users alleviate back pain in their homes and provides comprehensive back pain education, mindful pain reduction and personalized help from a coaching staff.

Users are visually monitored through their smartphone camera as they perform exercises and then get vocal feedback to correct posture and motion.

“We track every point on your body,” said Konstantin Mehl, CEO and co-founder of Kaia Health. “And that’s the cool thing about us — that we can give you feedback on a millimeter basis of what movements you do wrong if you want.”

Funding was led by venture capital firm Balderton Capital.

Balderton Capital partner James Wise said that oftentimes it is difficult to provide people with high-quality and affordable healthcare.

“Kaia Health is helping to tackle this through its revolutionary technology, which we believe could offer millions of chronic-pain sufferers best-in-class clinical solutions from the comfort of their own homes,” Wise said.

But this is not the first app of its kind.

Hinge Health has been working on an app-based solution to relieve back pain. And GeoPain allows users to track the frequency and severity of chronic pain while also mapping it on a 3D illustration of their body.

Get the best insights in healthcare analytics directly to your inbox.

Related

Mission Bio Raises $30M for Cancer-Focused Precision Medicine Tech

Precision Medicine, Sure. But What About Precision Payments?